(Times of Israel) Nathan Jeffay - Hebrew University researchers say an existing drug significantly downgrades the intensity of Covid-19. Fenofibrate, a generic medication to reduce lipids known as triglycerides, which is among the most prescribed drugs in the U.S., appeared to give patients an "astounding" advantage in fighting the disease, said Prof. Yaakov Nahmias. "This is a cheap and widely available drug with minimal side effects, and we were excited to find that all the main biomarkers indicate that it reduces the severity of Covid-19." 13 coronavirus patients who regularly took Fenofibrate to address their lipid levels had quicker-than-expected recovery from coronavirus-induced pneumonia. Nahmias said there is a "very high" chance that Fenofibrate will become a common treatment for coronavirus within a few months.
2020-12-24 00:00:00Full ArticleBACK Visit the Daily Alert Archive